Skip to main content
. Author manuscript; available in PMC: 2021 Sep 11.
Published in final edited form as: Subst Use Misuse. 2020 Sep 11;55(14):2364–2370. doi: 10.1080/10826084.2020.1817082

Table 1:

Sample Characteristics (N=324)

N %
Demographics and Background
Female 162 50.0%
Race/ethnicitya
 Hispanic 7 2.2%
 African American/Black 5 1.5%
 White 294 90.7%
 Other race/ethnicity 15 4.6%
Age (mean; SD) 37.31 (9.547)
Last grade completed in school (mean;SD) 11.40 (2.030)
SSP utilizer 189 58.3%
County of residence
 Clark 152 46.9%
 Knox 131 40.4%
 Owsley 41 12.7%
Substance Useb
 Alcohol 106 32.8%
 Marijuana 200 61.9%
 Cocainec 44 13.6%
 Crack cocainec 31 9.6%
 Heroinc 90 27.9%
 Ecstasyc 9 2.8%
 Methamphetamine 271 83.9%
 Benzodiazepinesc 98 30.3%
 Prescription stimulantsd 20 6.2%
 Prescription opioids 101 31.3%
 Buprenorphined 158 48.9%
 Fentanyld 45 13.9%
 Gabapentin 139 43.0%
Drug Injection
Injection frequencye,f (mean; SD) 91.33 (109.528)
Primary drug of injectiona
 Methamphetamine 169 52.2%
 Buprenorphine 67 20.7%
 Heroin 41 12.7%
 Prescription opioids 37 11.4%
 Other 7 2.2%
Health Problems
 Severe mental distressb 261 80.6%
 Severe substance use disorderb 208 64.2%
 Ever overdosed 119 36.7%
 A lot of physical pain or discomfortb 181 55.9%
Healthcare Service Utilization
 Ever substance use treatment 227 70.1%
 Unsuccessful treatment attemptb 45 13.9%
 Have a regular physician or clinic 160 49.4%
 Received care from a doctorg 225 69.4%
 Currently prescribed buprenorphine 48 14.8%
 Currently prescribed pain medication(s) 29 9.0%
a

three cases missing;

b

past 90 days;

c

one case missing;

d

two cases missing;

e

past 30 days;

f

17 cases DK/Refused;

g

past year